# Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM

> **NCT03608774** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 177 (actual)

## Conditions studied

- Anal Chlamydia Infection

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Doxycycline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03608774
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-13
- **Primary completion:** 2020-02-21
- **Final completion:** 2020-02-21
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2021-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03608774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03608774, "Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03608774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*